Traitement par biomédicament au cours du psoriasis : évaluation des pratiques professionnelles et des bénéfices-risques
P. Dessart(Centre Hospitalier du Mans), P. Celérier(Centre Hospitalier de La Rochelle), H. Maillard(Université de Tours), N. Bénéton(Centre Hospitalier du Mans), Camille Passot(Centre Hospitalier du Mans)
Cited by 0
Related Papers
Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
|Archives of Dermatology|2008|103
GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis
|British Journal of Dermatology|2018|84
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
|Journal of Oncology|2018|82
Management and outcome of metastatic melanoma during pregnancy
|British Journal of Dermatology|2009|71
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines
|Archives of Dermatological Research|1995|66